The Einstein-Montefiore Institute for Clinical and Translational Research (ICTR) has evolved over the past two CTSA funding periods, embracing the broad spectrum of clinical and translational (C/T) biomedical research from T1 through T4. We have provided pathways for our clinicians and our integrated healthcare system to expand implementation science, population health, community-engaged research, and clinical trials while also encouraging basic scientists to innovate new therapeutics and diagnostics. This broad involvement with our community and investigators has allowed the CTSA to impact a wide range of research extending from drug design and improving clinical trials management, to training a new research workforce, and to using implementation science for community-engaged and healthcare research. Indeed, the ICTR?s mission?to advance research across the translational spectrum into clinical practice through its integrated infrastructure, innovative training, and institutional co-investment?has evolved in step with that of the National Center for Advancing Translational Sciences. In this application, we will 1) leverage CTSA resources with institutional assets that support state-of-the-art informatics to accelerate the transfer of discoveries to healthcare via an Evidence Generation Framework, and support regulatory streamlining, innovative analytics, and assist with all phases of C/T research; 2) develop the next generation of research workforce and teams, using novel education, training, mentoring, pilot study support, and career development resources that span translational domains; 3) expand collaborations and engagement, both with the CTSA network and other hubs, and the Bronx community and healthcare partners in an integrative paradigm with strategies developed in collaboration with community partners, investigators, and institutional leadership to improve population health; 4) advance life span, child health, and aging research across genders and special populations, by working with unique platforms for stakeholder-engaged research, patient safety and implementation science, the Montefiore Accountable Care Organization, and the New York City Practice-Based Research Network; and 5) innovate methods and processes that advance C/T sciences, and enhance quality, safety, and efficiency of C/T research. We will integrate the CTSA Trial Innovation Network into our ecosystem of multisite clinical trials, foster innovative methods for biomarker assays and biobanking for precision medicine, and leverage the CTSA Common Metrics Initiative to support our hub?s Evaluation and strategic management. Overall, the Einstein- Montefiore ICTR will fulfill NCATS?s tripartite mission to innovate, educate, and implement.

Public Health Relevance

The Einstein-Montefiore Institute for Clinical and Translational Research (ICTR) supports laboratory and clinical research investigators working to bring new treatments to the public more quickly, safely and efficiently with the overall goal of improving population health. The mission of the ICTR is also to train the next generation of clinical and translational research teams so that they develop the competencies to apply new knowledge and processes, as well as to expand collaborations with the community and healthcare partners.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
1UL1TR002556-01
Application #
9624844
Study Section
Special Emphasis Panel (ZTR1)
Program Officer
Talbot, Bernard
Project Start
2018-03-22
Project End
2023-02-28
Budget Start
2018-03-22
Budget End
2019-02-28
Support Year
1
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine, Inc
Department
Type
DUNS #
079783367
City
Bronx
State
NY
Country
United States
Zip Code
10461
Blumen, Helena M; Brown, Lucy L; Habeck, Christian et al. (2018) Gray matter volume covariance patterns associated with gait speed in older adults: a multi-cohort MRI study. Brain Imaging Behav :
Reidy, Kimberly J; Hjorten, Rebecca; Parekh, Rulan S (2018) Genetic risk of APOL1 and kidney disease in children and young adults of African ancestry. Curr Opin Pediatr 30:252-259
Reidy, Kimberly J; Hjorten, Rebecca C; Simpson, Claire L et al. (2018) Fetal-Not Maternal-APOL1 Genotype Associated with Risk for Preeclampsia in Those with African Ancestry. Am J Hum Genet 103:367-376
Auld, Sara C; Shah, N Sarita; Mathema, Barun et al. (2018) Extensively drug-resistant tuberculosis in South Africa: genomic evidence supporting transmission in communities. Eur Respir J 52:
Hunter, Liane E; Ifrah, Chloe; Zimmerman, Molly E et al. (2018) Heading and unintentional head impacts have opposing associations with Patient Reported Outcomes in amateur soccer players. Res Sports Med 26:390-400
Weinstein, Erica J; Levene, Jacob L; Cohen, Marc S et al. (2018) Local anaesthetics and regional anaesthesia versus conventional analgesia for preventing persistent postoperative pain in adults and children. Cochrane Database Syst Rev 4:CD007105
Isasi, Carmen R; Strizich, Garrett M; Kaplan, Robert et al. (2018) The association of cardiorespiratory fitness with cardiometabolic factors, markers of inflammation, and endothelial dysfunction in Latino youth: findings from the Hispanic Community Children's Health Study/Study of Latino Youth. Ann Epidemiol 28:583-589.e3
Lucan, Sean C; Maroko, Andrew R; Seitchik, Jason L et al. (2018) Sources of Foods That Are Ready-to-Consume ('Grazing Environments') Versus Requiring Additional Preparation ('Grocery Environments'): Implications for Food-Environment Research and Community Health. J Community Health 43:886-895
Taneva, Ekaterina; Sinclair, Shada; Mesquita, Pedro Mm et al. (2018) Vaginal microbiome modulates topical antiretroviral drug pharmacokinetics. JCI Insight 3:
Fox, Robert J; Coffey, Christopher S; Conwit, Robin et al. (2018) Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis. N Engl J Med 379:846-855

Showing the most recent 10 out of 33 publications